Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05321563 · ClinicalTrials.gov registry record · NA
Evaluating the Effectiveness of a Drug Education and Diversion Program for Middle and High School Students
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT05321563: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT05321563 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 132 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05321563, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
The primary goal of this study is to evaluate the effectiveness of the iDECIDE curriculum as an alternative to punitive responses for school-based substance use infractions.
Interventions
- BEHAVIORAL iDECIDE (Drug Education Curriculum: Intervention, Diversion, and Empowerment)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2022-02-04 |
| Est. Completion | 2023-09-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05321563
The ClinicalTrials.gov registry entry for NCT05321563 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which iDECIDE (Drug Education Curriculum: Intervention, Diversion, and Empowerment) is the first listed.
NCT05321563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05321563 about?
NCT05321563 is a clinical study titled "Evaluating the Effectiveness of a Drug Education and Diversion Program for Middle and High School Students". The primary goal of this study is to evaluate the effectiveness of the iDECIDE curriculum as an alternative to punitive responses for school-based substance use infractions.
What is the current status of trial NCT05321563?
This trial is currently terminated. It is a NA study. The enrollment target is 132 participants. The study started on 2022-02-04. Estimated completion is 2023-09-14.
What interventions are being tested in trial NCT05321563?
The interventions under investigation include: iDECIDE (Drug Education Curriculum: Intervention, Diversion, and Empowerment) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05321563?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.